300 likes | 974 Views
Primitive (found in all multicellular organisms) Directed towards types of molecules Effectors are broadly reactive Response is immediate No anamnestic responses Effectors: epithelial cells, phagocytes, endothelial cells, fibroblasts. Only in vertebrates Directed towards specific epitopes
E N D
Primitive (found in all multicellular organisms) Directed towards types of molecules Effectors are broadly reactive Response is immediate No anamnestic responses Effectors: epithelial cells, phagocytes, endothelial cells, fibroblasts Only in vertebrates Directed towards specific epitopes Response is slow Effectors are highly specific Memory persists Effectors: Lymphocytes, APCs Innate vs. Adaptive Immunity Adaptive Innate
Adaptive Immunity
Defects in Innate Immunity • Chronic granulomatous disease--CGD (pyogenic infections, Aspergillus) • Burns/chemotherapy: Loss of barrier integrity (bacteria, yeasts) • Neutropenia (bacteria, yeasts, molds) • Rare specific defects in cytokines/receptors (susceptibility to particular infections) • Complement deficiencies (meningococcus) • Corticosteroids (Aspergillus, Candida, herpesviruses)
Defects in Adaptive Immunity • SCID--no T or B cells (severe, fatal infections) • AIDS--loss of CD4+ T cells (Intracellular pathogens, fungi, viruses, pyogenic infections, etc.) • Transplant--immunsuppression of T cells (viral, fungal) • Common Variable Immunodeficiency (decreased IgG)--generally mild increase in sinopulmonary bacterial infections • Asplenia--encapsulated bacteria • Corticosteroids
Molecular features of Innate Immunity • Certain proteins are vital to functioning of the innate immune system • Both natural and acquired defects in these proteins give clues to their roles in defense. • These proteins are present in a wide variety of species
Normal fruit fly Fruit fly lacking Toll
Newly described PRRs • TLR11--identifies uropathogenic E. coli in humans (not clear what molecule yet) • Nod1--intracellular receptor with N-terminal CARD domain and C-terminal LRRs. Recognizes intracellular Shigella flexneri • Nod2--similar to Nod1. Ligand not known, but is associated with Crohn’s disease
TLR IL-1R cell membrane p85 TIR domains } { WM MyD88 p110 Adaptors (Rac1, ? ceramide) PI 3-kinase IRAK Pi PI(3,4,5)- P3 TRAF-6 NIK Akt Erk Pi Bay11 Pi IKK Pi I-kB I-kB NF-kB NF-kB p38 AP-1 SB Inflammatory genes (chemokines, cytokines, etc) NF-kB nucleus
FliC TLR5 PI3K IRAK/TRAF-6 WM Bay11 Akt ? I-B degradation p38 ? LY NF-B activation NF-IL-6 AP-1 (50%) IL-8 transcription LY IL-8 mRNA IL-8 degradation
Ag T cell macrophage/DC B cell TLRs and adaptive immunity:old paradigm
mature DC CD80/CD86 CD28 TCR T-cell No activation/ anergy Activation clonal proliferation
New paradigm of TLR-controlled DC activity tissue lymph node IL-10 No ligand clonal deletion Treg cell immature DC Ag + TLR ligand Immature DC IL-12 TNF- IL-6 Th1 cell Mature DC